Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil to Enhance Sleep Deprivation in Depression
NCT00670813Phase 2Withdrawn
- Sponsor
- Technical University of Munich
- Start
- May 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of modafinil in major depressive disorder (MDD), bipolar disorder (BD), sponsored by Technical University of Munich. Planned start May 2008; status: withdrawn.
02
Drugs
modafinil
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00670813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00670813.